Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox in young patients with glabellar furrows
NCT00856999Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Feb 2005
- Primary completion
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, open-label, single-arm trial of botulinum toxin type A in glabellar lines, sponsored by Oregon Health & Science University. Primary endpoints: Reduction of the Facial Wrinkle Scale at 26 months and Patient Assessed Frown-line Improvement at 20 months. Started Feb 2005; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT00856999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00856999.